RenovoRx Inc
Change company Symbol lookup
Select an option...
RNXT RenovoRx Inc
OCGN Ocugen Inc
NEGG Newegg Commerce Inc
PHX PHX Minerals Inc
IRT Independence Realty Trust Inc
RLAY Relay Therapeutics Inc
CVU CPI Aerostructures Inc
MA Mastercard Inc
WDBG Neuro-Hitech Inc
GLRY Inspire Faithward Mid Cap Momentum ETF
Go

Health Care : Biotechnology |
Company profile

RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which is focused on developing therapies for the local treatment of solid tumors and conducting a Phase III pancreatic cancer clinical trial for its lead product candidate RenovoGem. The Company’s therapy platform, RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMP) utilizes chemotherapeutics. RenovoTAMP combines its patented delivery system, RenovoCath, with small molecule chemotherapeutic agents, which can be forced across the vessel wall using pressure, targeting these anti-cancer drugs locally to the solid tumors. Its first product candidate, RenovoGem, is a drug /device combination consisting of intra-arterial gemcitabine and RenovoCath. RenovoGem has developed for the treatment of two rare diseases: pancreatic cancer and cholangiocarcinoma (CCA). It has completed its Phase I/II and observational registry studies, with 20 and 25 patients respectively, in locally advanced pancreatic cancer (LAPC).

Closing Price
$3.03
Day's Change
0.04 (1.34%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.30
Day's Low
2.90
Volume
(Heavy Day)
Volume:
64,735

10-day average volume:
23,929
64,735
  • Prev Close
    2.99
  • Today's Open
    3.00
  • Day's Range
    2.90-3.30
  • Avg Vol (10-day)
    23.9K
  • Last (time)
    4:00p ET 03/28/23
  • Last (size)
    4
  • 52-Wk Range
    1.50 - 5.75
    LowHigh
  • (12/06/22 - 03/07/23)
    102.00%
  • 101.3%
  • Market Cap
    27.6M
  • Shares Outstanding
    9.1M
  • -1.31
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 12.97
  • (% of float 02/28/23)
    0.12

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.